Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Letsch, Anne
- Contributor
-
Scheibenbogen, Carmen
Busse, Antonia
Ochsenreither, Sebastian
Blau, Igor Wolfgang
Baldus, Claudia
Thiel, Eckhard
Keilholz, Ulrich
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P223
- URN
-
urn:nbn:de:1111-2016072654430
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Letsch, Anne
- Scheibenbogen, Carmen
- Busse, Antonia
- Ochsenreither, Sebastian
- Blau, Igor Wolfgang
- Baldus, Claudia
- Thiel, Eckhard
- Keilholz, Ulrich
- SpringerLink (Online service)
Other Objects (12)
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie